Actively Recruiting
Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency
Led by University Hospital, Caen · Updated on 2025-07-25
30
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Preclinical evaluation of a vitamin D analog for the treatment of vitamin D 24-hydroxylase using fibroblast from patients with CYP24A1 mutation.
CONDITIONS
Official Title
Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biallelic mutation in CYP24A1
- Provided consent to participate
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Arnaud Molin
Caen, Normandy, France, 14033
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here